A high rate of venous thromboembolism in a multi-institutional phase II trial of weekly intravenous gemcitabine with continuous infusion fluorouracil and daily thalidomide in patients with metastatic renal cell carcinoma
収録刊行物
-
- Cancer (Phila)
-
Cancer (Phila) 95 1629-1636, 2002